Cargando…

Does Doxycycline work in synergy with cisplatin and oxaliplatin in colorectal cancer?

BACKGROUND: In recent years, apart from antibacterial properties, doxycycline is reported to have cytotoxic and anti-proliferative actions in various cancers including colorectal cancer. Colorectal cancer constitutes one of the most common cancers in the western population. Apart from surgery, chemo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagar, Jayesh, Sales, Kevin, Dijk, Sas, Taanman, JanWillem, Seifalian, Alexander, Winslet, Mark
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628910/ https://www.ncbi.nlm.nih.gov/pubmed/19126215 http://dx.doi.org/10.1186/1477-7819-7-2

Ejemplares similares

Lowering the apoptotic threshold in colorectal cancer cells by targeting mitochondria
por: Sagar, Jayesh, et al.
Publicado: (2010)

Role of stem cells in cancer therapy and cancer stem cells: a review
por: Sagar, Jayesh, et al.
Publicado: (2007)

Mitochondria as target to inhibit proliferation and induce apoptosis of cancer cells: the effects of doxycycline and gemcitabine
por: Dijk, Sas N., et al.
Publicado: (2020)

IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells
por: Yang, Shi Yu, et al.
Publicado: (2009)

Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells
por: Ganesh, Radhakrishnan, et al.
Publicado: (2012)

Clonal Expansion of T Cells in Abdominal Aortic Aneurysm: A Role for Doxycycline as Drug of Choice?
por: Kroon, Albert M., et al.
Publicado: (2015)

Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3
por: Protasoni, Margherita, et al.
Publicado: (2018)

Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide
por: Yang, Shi Yu, et al.
Publicado: (2008)

In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold
por: Gupta, Ashish, et al.
Publicado: (2009)

Tirapazamine-cisplatin: the synergy.
por: Gatzemeier, U., et al.
Publicado: (1998)

On the synergy between silver nanoparticles and doxycycline towards the inhibition of Staphylococcus aureus growth
por: Silva, Heloiza F. O., et al.
Publicado: (2018)

Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin
por: Ren, Li-Qun, et al.
Publicado: (2020)

Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71
por: Brochmann, Rikke Prejh, et al.
Publicado: (2016)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus
por: Khan, A N, et al.
Publicado: (2006)

Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2020)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibody Treatments
por: Mehmood, Rao Khalid
Publicado: (2014)

Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective
por: Mehmood, Rao Khalid, et al.
Publicado: (2014)

Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models
por: Cardoso, Isabel, et al.
Publicado: (2010)

Clinical Potential of Quantum Dots
por: Iga, Arthur M., et al.
Publicado: (2007)

Role of insulin-like growth factor binding protein-4 in prevention of colon cancer
por: Durai, Rajaraman, et al.
Publicado: (2007)

Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity
por: Hellberg, Victoria, et al.
Publicado: (2009)

Cisplatin, Oxaliplatin, and Kiteplatin Subcellular Effects Compared in a Plant Model
por: Papadia, Paride, et al.
Publicado: (2017)

Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
por: Skripova, Vera, et al.
Publicado: (2022)

Culture media, DMSO and efflux affect the antibacterial activity of cisplatin and oxaliplatin
por: Gupta, A., et al.
Publicado: (2022)

Role of oxaliplatin in the treatment of colorectal cancer
por: Comella, Pasquale, et al.
Publicado: (2009)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin
por: Sutton, Emily C., et al.
Publicado: (2021)

Reactions of cisplatin and oxaliplatin with penicillin G: implications for drug inactivation and biological activity
por: Wang, Fang-Xin, et al.
Publicado: (2022)

Periodic Oxaliplatin Administration in Synergy with PER2‐Mediated PCNA Transcription Repression Promotes Chronochemotherapeutic Efficacy of OSCC
por: Tang, Qingming, et al.
Publicado: (2019)

Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells
por: Wróblewska-Łuczka, Paula, et al.
Publicado: (2021)

Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells
por: Songjang, Worawat, et al.
Publicado: (2022)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2
por: Sun, Wei, et al.
Publicado: (2021)

Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors
por: Azmi, Asfar S., et al.
Publicado: (2011)

In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells
por: Ganot, N., et al.
Publicado: (2018)

Generational Differences in Work-Family Conflict and Synergy
por: Beutell, Nicholas J.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_403j8oa0jaqde783fk8b54dvp3